| Name | Title | Contact Details |
|---|
Tropiclean Pet Products, a division of Cosmos Corporation, has been providing pet owners and professionals with innovative solutions in the pet care category for over 20 years.
Based in Chicago, BrightStar Care is a national private duty home care and medical staffing franchise with more than 280 locations that can provide medical and non-medical services to clients within their homes, as well as supplemental care staff to corporate clients. BrightStar Care professional nurses and caregivers deliver expert, compassionate, and personal care 24 hours a day, 7 days a week. Each BrightStar Care location is required to pursue Joint Commission Accreditation. BrightStar Care received The Joint Commission`s Enterprise Champion for Quality award in 2013, 2014, and 2015, and is committed to having each of its agencies comply with Joint Commission standards. BrightStar Care uses the nationally known patient satisfaction survey company Press Ganey to measure client satisfaction and is proud that nine out of 10 clients would recommend BrightStar Care to a friend or family member.
Connecticut Hospital Association is a Wallingford, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Capital City Nurses is a Chevy Chase, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Cleveland BioLabs, Inc. (NASDAQ: CBLI) is an innovative bio pharmaceutical company developing novel approaches to activate the immune system and address serious medical needs. Our proprietary platform of toll-like immune receptor activators has applications in radiation mitigation, oncology immunotherapy, and vaccines. We combine our proven scientific expertise and our depth of knowledge about our products’ mechanisms of action into a passion for developing drugs to save lives. Our proprietary drug candidates act via unique mechanisms that are designed to kill cancer and protect healthy cells. Our most advanced product candidate is entolimod, which we are developing as a radiation countermeasure and an immunotherapy for oncology and other indications. We have additional pipeline product candidates in various stages of development.